Persistence with IDegLira in Patients in Clinical Practice: A Nationwide Observational Study in Sweden.

ABSTRACT:

Aims

To explore persistence with insulin degludec/liraglutide (IDegLira) treatment, clinical characteristics and concomitant medications in a large population of patients in clinical practice.

Methods

This was an observational study in patients with type 2 diabetes (n = 2432) who initiated IDegLira between 26 May 2015 and 31 December 2017. Data were obtained from Swedish nationwide registers and linked on an individual level using unique Swedish personal identifiers. Dose calculations were made for patients with ≥ 180 days between the first and last collections of IDegLira prescription. Changes in clinical parameters were evaluated as change from the last observation during 12 months prior to the initiation date until ± 90 days from the last collection of IDegLira.

Result

SUBMITTER: Eliasson B 

PROVIDER: S-EPMC7376998 | biostudies-literature | 2020 Aug

REPOSITORIES: biostudies-literature